CoChat

Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study

Open access
Martinotti, Giovanni, Di Nicola, Marco, De Vita, Ofelia, Hatzigiakoumis, Daniele Stavros, Guglielmo, Riccardo, Santucci, Barbara, Aliotta, Fererica, Romanelli, Roberto, Verrastro, Valeria, Petruccelli, Filippo, Di Giannantonio, Massimo, Janiri, Luigi · 2014 · Journal of Clinical Psychopharmacology
Cited by 48

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Topiramate (TOP) and anticonvulsants in general are considered safe and effective drugs for the treatment of alcohol dependence, even though TOP-induced adverse events are quite common, especially for high initial doses or if titration to 300 mg/d is too rapid. The aim of the present study was to assess the efficacy and tolerability profile of low-dose TOP for relapse prevention. METHODS: After detoxification, 52 patients were randomized into 2 groups as follows: 26 patients received 100 mg of TOP (oral, twice daily), titrated over 2 weeks, and 26 patients received placebo (PLA). Both groups underwent rehabilitation twice a week. RESULTS: After 6 weeks of treatment, compared with the PLA group, patients receiving TOP showed the following: (1) fewer drinking days (P < 0.05); (2) less daily alcohol consumption (P < 0.05); (3) more days of treatment (P < 0.05); (4) reduced levels of craving (Obsessive-Compulsive Drinking Scale) and withdrawal symptoms (Clinical Institute Withdrawal Assessment for Alcohol-Revised); and (5) improvement of anxiety, depression, and obsessive-compulsive symptom severity (Symptom Check List 90 Revised). CONCLUSIONS: Despite the small sample size and the short follow-up period, the present PLA-controlled study demonstrated the potential usefulness of TOP, even when administered at a dosage of 100 mg/d, for the treatment of detoxified alcohol-dependent subjects, confirming results from previous studies testing higher doses of TOP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000000228

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 48

Metadata

Authors
Martinotti, G., Di Nicola, M., De Vita, O., Hatzigiakoumis, D. S., Guglielmo, R., Santucci, B., Aliotta, F., Romanelli, R., Verrastro, V., Petruccelli, F., Di Giannantonio, M., & Janiri, L.
Venue
Journal of Clinical Psychopharmacology
Published
2014-12
Volume
34
Issue
6
Pages
709-715
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1967507587
Cited by
48
References
8
FWCI
4.27
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.1097/jcp.0000000000000228
The paper
Martinotti, G., Di Nicola, M., De Vita, O., Hatzigiakoumis, D. S., Guglielmo, R., Santucci, B., Aliotta, F., Romanelli, R., Verrastro, V., Petruccelli, F., Di Giannantonio, M., & Janiri, L. (2014). Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.